Prevention of diseases after menopause

References

• Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865–74
   PubMed Web of Science ®Google Scholar
• Dratva J, Gomez RF, Schindler C. Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies. Menopause 2009;16: 385–94
   PubMed Web of Science ®Google Scholar
• Kriplani A, Banerjee K. An overview of age of onset of menopause in northern India. Maturitas 2005;52:199–204
   PubMed Web of Science ®Google Scholar
• Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med 1992;326: 1406–16
   PubMed Web of Science ®Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310:1353–68
   PubMed Web of Science ®Google Scholar
• Kim C, Cleary PA, Cowie CC, et al. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort. Diabetes Care 2014;37:701–8
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation 2014;129:e28–292
   PubMed Web of Science ®Google Scholar
• Ebong IA, Watson KE, Goff DC Jr, et al. Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis. Menopause 2014;21:585–91
   PubMed Web of Science ®Google Scholar
• Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause 2012;19:1081–7
   PubMed Web of Science ®Google Scholar
• Tom SE, Cooper R, Wallace RB, Guralnik JM. Type and timing of menopause and later life mortality among women in the Iowa Established Populations for the Epidemiological Study of the Elderly (EPESE) cohort. J Womens Health (Larchmt) 2012;21:10–16
   PubMed Web of Science ®Google Scholar
• Compston J. How to manage osteoporosis after the menopause. Best Pract Res Clin Rheumatol 2005;19:1007–19
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int 2005;16(Suppl 2):S3–7
   PubMed Web of Science ®Google Scholar
• Pirro M, Fabbriciani G, Leli C, et al. High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab 2010;28:88–93
   PubMed Web of Science ®Google Scholar
• Briggs AM, Greig AM, Wark JD. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporos Int 2007;18:575–84
   PubMed Web of Science ®Google Scholar
• Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011;7:137–52
   PubMed Web of Science ®Google Scholar
• Hosseini MS, Arab M, Nemati HB, et al. Age-specific incidence rate change at breast cancer and its different histopathologic subtypes in Iran and Western countries. Pak J Med Sci 2013; 29:1354–7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers 2014;29:e21–9
   PubMed Web of Science ®Google Scholar
• Lee H, Li JY, Fan JH, et al. Risk factors for breast cancer among Chinese women: a 10-year nationwide multicenter cross-sectional study. J Epidemiol 2014;24:67–76
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity and overweight. Fact sheet No. 311, May 2012. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
   Google Scholar
• Pace G, Silvestri V, Guala L, Vicentini C. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health. Menopause 2009;16:1188–92
   PubMed Web of Science ®Google Scholar
• Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 2002;44:127–38
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78
   PubMed Web of Science ®Google Scholar
• Istvan J, Zavela K, Weidner G. Body weight and psychological distress in NHANES I. Int J Obes Relat Metab Disord 1992;16:999–1003
   PubMed Web of Science ®Google Scholar
• Cicuttini FM, Baker JR, Spector TD. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 1996;23:1221–6
   PubMed Web of Science ®Google Scholar
• Botlero R, Davis SR, Urquhart DM, Shortreed S, Bell RJ. Age-specific prevalence of, and factors associated with, different types of urinary incontinence in community-dwelling Australian women assessed with a validated questionnaire. Maturitas 2009;62:134–9
   PubMed Web of Science ®Google Scholar
• Global Health Observatory. Obesity. Geneva: World Health Organization, 2014. Available at: http://www.who.mt/gho/ncd/risk_factors/obesity
   Google Scholar
• Jacoby E, Goldstein J, Lopez A, Nunez E, Lopez T. Social class, family, and life-style factors associated with overweight and obesity among adults in Peruvian cities. Prev Med 2003;37:396–405
   PubMed Web of Science ®Google Scholar
• Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70 years, in the north of Iran: a population-based study and regression approach. Obes Rev 2007;8:3–10
   PubMed Web of Science ®Google Scholar
• Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011;378:804–14
   PubMed Web of Science ®Google Scholar
• Fonken LK, Workman JL, Walton JC, et al. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci USA 2010;107:18664–9
   PubMed Web of Science ®Google Scholar
• Sutin AR, Zonderman AB. Depressive symptoms are associated with weight gain among women. Psychol Med 2012;42: 2351–60
   PubMed Web of Science ®Google Scholar
• Pan A, Lucas M, Sun Q, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 2010;170:1884–91
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Moore SC, Jacobs EJ, et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc 2014;89:335–45
   PubMed Web of Science ®Google Scholar
• Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr 2006; 83:47–51
   PubMed Web of Science ®Google Scholar
• Sternfeld B, Wang H, Quesenberry CP Jr, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;160:912–22
   PubMed Web of Science ®Google Scholar
• Guthrie JR, Dennerstein L, Dudley EC. Weight gain and the menopause: a 5-year prospective study. Climacteric 1999; 2:205–11
   PubMedGoogle Scholar
• Franklin RM, Ploutz-Snyder L, Kanaley JA. Longitudinal changes in abdominal fat distribution with menopause. Metabolism 2009;58:311–15
   PubMed Web of Science ®Google Scholar
• Abdulnour J, Doucet E, Brochu M, et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal–Ottawa New Emerging Team group study. Menopause 2012;19:760–7
   PubMed Web of Science ®Google Scholar
• Ho SC, Wu S, Chan SG, Sham A. Menopausal transition and changes of body composition: a prospective study in Chinese perimenopausal women. Int J Obes (Lond) 2010;34:1265–74
   PubMed Web of Science ®Google Scholar
• Han TS, van Leep EM, Serdeel JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence in a random sample. BMJ 1995;311: 1401–5
   PubMed Web of Science ®Google Scholar
• Cust AE, Stocks T, Lukanova A, et al. The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat 2009;113:567–76
   PubMed Web of Science ®Google Scholar
• Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152–63
   PubMed Web of Science ®Google Scholar
• Davis SR, Robinson PJ, Moufarege A, Bell RJ. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women. Clin Endocrinol (Oxf) 2012;77:541–7
   PubMed Web of Science ®Google Scholar
• Flechtner-Mors M, Schick A, Oeztuerk S, et al. Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1657 subjects. Horm Metab Res 2014;46:287–93
   PubMed Web of Science ®Google Scholar
• Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S. Correlation between the adiponectin–leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 2005;54:281–6
   PubMed Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167–74
   PubMed Web of Science ®Google Scholar
• Dubnov-Raz G, Berry EM. The dietary treatment of obesity. Med Clin N Am 2011;95:939–52
   PubMed Web of Science ®Google Scholar
• Buchanan D. Ethical standards to guide the development of obesity policies and programs. Comment on ‘Ethical agreement and disagreement about obesity prevention policy in the United States’. Int J Health Policy Manag 2013;1:313–15
   PubMedGoogle Scholar
• Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric 2012;15:419–29
   PubMed Web of Science ®Google Scholar
• Sorensen MB, Rosenfalck AM, Hojgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res 2001;9:622–6
   PubMedGoogle Scholar
• Yuksel H, Odabasi AR, Demircan S, et al. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition. Gynecol Endocrinol 2006;22:381–7
   PubMed Web of Science ®Google Scholar
• Davis SR, Walker KZ, Strauss BJ. Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women. Menopause 2000; 7:395–401
   PubMed Web of Science ®Google Scholar
• Goldberg R, Temprosa M, Otvos J, et al. Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab 2013;98:3989–98
   PubMed Web of Science ®Google Scholar
• Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 2014;16:719–27
   PubMed Web of Science ®Google Scholar
• Lee CM, Colagiuri R, Magliano DJ, et al. The cost of diabetes in adults in Australia. Diabetes Res Clin Pract 2013;99:385–90
   PubMed Web of Science ®Google Scholar
• Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus – present and future perspectives. Nat Rev Endocrinol 2012;8:228–36
   Web of Science ®Google Scholar
• American Heart Association. https://www.heart.org/gglRisk/
   Google Scholar
• Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82–96
   PubMed Web of Science ®Google Scholar
• Spring B, Ockene JK, Gidding SS, et al. Better population health through behavior change in adults: a call to action. Circulation 2013;128:2169–76
   PubMed Web of Science ®Google Scholar
• Maruthur NM, Wang N-Y, Appel LJ. Lifestyle interventions reduce coronary artery disease risk. Results from the PREMIER trial. Circulation 2009;119:2026–31
   PubMed Web of Science ®Google Scholar
• Saha S, Carlsson KS, Gerdtham U-G, et al. Are lifestyle interventions in primary care cost-effective? An analysis based on a Markov model, differences-in-differences approach and the Swedish Bjorknas study. PLOS One 2013;8, e80672:1–10
   Google Scholar
• Hodis HN, Mack WJ. The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. 1. Comparison of therapeutic efficacy. J Am Geriatr Soc 2013;61:1005–10
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ. The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. 2. Comparative risks. J Am Geriatr Soc 2013;61:1011–18
   PubMed Web of Science ®Google Scholar
• Walsh JME, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243–52
   PubMed Web of Science ®Google Scholar
• Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M. Impact of gender in primary prevention of coronary heart disease with stain therapy: a meta-analysis. Int J Cardiol 2010;138:25–31
   PubMed Web of Science ®Google Scholar
• Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009;338:b2376
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JME, Greyber E, Salpeter EE. Coronary heart disease events associated with hormone therapy in younger and older women: a meta-analysis. J Gen Intern Med 2006; 21:363–6
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JME, Greybe, E, Ormiston TM, Salpeter EE. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004;19:791–804
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Cheng J, Thabane L, Buckley NS, Salpeter EE. Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med 2009;122:1016–22
   PubMed Web of Science ®Google Scholar
• Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306–13
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293–304
   PubMed Web of Science ®Google Scholar
• Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial. BMJ 2012;345:e6409
   PubMed Web of Science ®Google Scholar
• Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35:1024–33
   PubMed Web of Science ®Google Scholar
• Gutierrez J, Ramirez G, Rundek T, Sacco RL. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med 2012;172:909–19
   PubMed Web of Science ®Google Scholar
• Reginster JY, Seeman E, De Vernejoul MC, et al.;Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005;90:2816–22
   PubMed Web of Science ®Google Scholar
• Cauley JA, Thompson DE, Ensrad KC, et al. Risk of mortality following clinical fractures. Osteoporos Int 2000;11:556–61
   PubMed Web of Science ®Google Scholar
• Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1977;7:407–13
   Google Scholar
• Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 2007;22:465–75
   PubMed Web of Science ®Google Scholar
• De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16:1330–8
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. website: www.iom.edu/Reports/2010/Dietary
   Google Scholar
• Boland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691
   Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Willett W, et al. Fall prevention by vitamin D treatment: a meta-analysis of randomized controlled trials. JAMA 2004;291:1999–2006
   PubMed Web of Science ®Google Scholar
• The Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Jackson RD, Wactawski-Wende J, LaCroix AZ, et al. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial. J Bone Miner Res 2006;21:817–28
   PubMed Web of Science ®Google Scholar
• Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290:1729–38
   PubMed Web of Science ®Google Scholar
• De Villiers TJ. Individualized therapy for osteoporosis prevention and treatment in women under 60. Climacteric 2009;12: 210–12
   PubMed Web of Science ®Google Scholar
• De Villiers TJ, Stevenson J. The WHI: The effect of hormone replacement therapy on fracture prevention. Climacteric 2012;15:263–6
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;7:1465–77
   Google Scholar
• De Villiers TJ, Gass MLS, Haines CJ, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16:203–4
   PubMed Web of Science ®Google Scholar
• De Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
   PubMed Web of Science ®Google Scholar
• Ettinger B, Black DM, Mitlak BH, et al.; Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999;282:637–45
   PubMed Web of Science ®Google Scholar
• Martino S, Cauley JA, Barrett-Connor E, et al. for CORE Investigators. Continuing outcomes relevant to Evista; breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 2004; 96:1751–61
   PubMed Web of Science ®Google Scholar
• De Villiers TJ, Chines AA, Palacios S, et al. Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial. Osteoporos Int 2011;22:567–76
   PubMed Web of Science ®Google Scholar
• De Villiers TJ. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis. Climacteric 2010;13:210–18
   PubMed Web of Science ®Google Scholar
• Lindsay R, Gallagher JC, Kagan R, et al. Efficacy of tissue- selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril 2009;92:1045–52
   PubMed Web of Science ®Google Scholar
• Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998;280:2077–82
   PubMed Web of Science ®Google Scholar
• Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008;358:1304–6
   PubMed Web of Science ®Google Scholar
• Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res 2009;24:1095–102
   PubMed Web of Science ®Google Scholar
• Colon-Emeric C. Editorial. Ten vs five years of bisphosphonate treatment for osteoporosis. JAMA 2006;296:2968–9
   PubMed Web of Science ®Google Scholar
• Black DM, Delmas PD, Eastell R, et al.; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809–22
   PubMed Web of Science ®Google Scholar
• Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995;38: 1134–41
   PubMed Web of Science ®Google Scholar
• Weinstein JN, Barmier JD. The Dartmouth Atlas of Musculoskeletal Health Care. Chicago: American Hospital Association Press, 2000
   Google Scholar
• Arthritis Foundation, 2014. www.arthritis.org/conditions-treatments/disease-center/osteoarthritis
   Google Scholar
• Tanko LB, Christiansen C, Karsdal MA. Potentials of estrogens in the prevention of osteoarthritis: what do we know and what questions are still pending? In Lobo RA, ed. Treatment of the Postmenopausal Woman. Academic Press, 2007:393–401
   Google Scholar
• Weber MT, Mapstone M, Staskiewicz J, Maki PM. Reconciling subjective memory complaints with objective memory performance in the menopausal transition. Menopause 2012;19:735–41
   PubMed Web of Science ®Google Scholar
• Henderson VW. Gonadal hormones and cognitive aging: a midlife perspective. Women’s Health (Lond Engl) 2011;7: 81–93
   PubMedGoogle Scholar
• Salthouse TA. When does age-related cognitive decline begin?Neurobiol Aging 2009;30:507–14
   PubMed Web of Science ®Google Scholar
• Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause 2007;14:572–9
   PubMed Web of Science ®Google Scholar
• Bove R, Secor E, Chibnik LB, et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 2014;82:222–9
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Ahlskog JE, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69: 1074–83
   PubMed Web of Science ®Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med 2010;362:329–44
   PubMed Web of Science ®Google Scholar
• Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69:2197–204
   PubMed Web of Science ®Google Scholar
• Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med 2012;367:795–804
   PubMed Web of Science ®Google Scholar
• Henderson VW. Three midline strategies to prevent cognitive impairment due to Alzheimer's disease. Climacteric 2014 June 4. Epub ahead of print
   Web of Science ®Google Scholar
• Stampfer MJ. Cardiovascular disease and Alzheimer’s disease: common links. J Intern Med 2006;260:211–23
   PubMed Web of Science ®Google Scholar
• Dolan H, Crain B, Troncoso J, et al. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol 2010;68:231–40
   PubMed Web of Science ®Google Scholar
• Stern Y. Cognitive reserve in aging and Alzheimer’s disease. Lancet Neurol 2012;11:1006–12
   PubMed Web of Science ®Google Scholar
• Sofi F, Valecchi D, Bacci D, et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 2011;269:107–17
   PubMed Web of Science ®Google Scholar
• Williams JW, Plassman BL, Burke J, et al. Preventing Alzheimer’s Disease and Cognitive Decline. Evidence Report/Technology Assessment Number 193. Department of Health and Human Services, Rockville, MD, 2010. AHRQ Publication No. 10-E005
   Google Scholar
• Liu HL, Zhao G, Zhang H, Shi LD. Long-term treadmill exercise inhibits the progression of Alzheimer’s disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 2013;256:261–72
   PubMed Web of Science ®Google Scholar
• Liang KY, Mintun MA, Fagan AM, et al. Exercise and Alzheimer’s disease biomarkers in cognitively normal older adults. Ann Neurol 2010;68:311–18
   PubMed Web of Science ®Google Scholar
• Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011;108:3017–22
   PubMed Web of Science ®Google Scholar
• Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007;30:464–72
   PubMed Web of Science ®Google Scholar
• Kobilo T, Liu QR, Gandhi K, et al. Running is the neurogenic and neurotrophic stimulus in environmental enrichment. Learning Memory 2011;18:605–9
   PubMed Web of Science ®Google Scholar
• Korol DL, Gold PE, Scavuzzo CJ. Use it and boost it with physical and mental activity. Hippocampus 2013;32:125–35
   Google Scholar
• Vest RS, Pike CJ. Gender, sex steroid hormones, and Alzheimer’s disease. Horm Behav 2013;63:301–7
   PubMed Web of Science ®Google Scholar
• Bailey ME, Wang AC, Hao J, et al. Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging. Neuroscience 2011;191:148–58
   PubMed Web of Science ®Google Scholar
• Ding F, Yao J, Zhao L, et al. Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer’s disease. PLoS One 2013;8:e59825
   PubMed Web of Science ®Google Scholar
• McClure RE, Barha CK, Galea LA. 17β-Estradiol, but not estrone, increases the survival and activation of new neurons in the hippocampus in response to spatial memory in adult female rats. Horm Behav 2013;63:144–57
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study (WHIMS). JAMA 2003;289:2651–62
   PubMed Web of Science ®Google Scholar
• Henderson VW, Benke KS, Green RC, et al. Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005;76:103–5
   PubMed Web of Science ®Google Scholar
• Shao H, Breitner JCS, Whitmer RA, et al. Hormone therapy and AD dementia: new findings from the Cache County study. Neurology 2012;79:1846–52
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011;69:163–9
   PubMed Web of Science ®Google Scholar
• Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288:2170–2
   PubMed Web of Science ®Google Scholar
• Asthana S, Gleason CE, Wharton W, et al. The Kronos Early Estrogen Prevention Study: results of the Cognitive & Affective Sub-Study (KEEPS Cog). Menopause 2012;19:1364 (Abstr)
   PubMedGoogle Scholar
• Henderson VW, Popat RA. Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions. Neuroscience 2011;191:129–38
   PubMed Web of Science ®Google Scholar
• Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293–9
   PubMed Web of Science ®Google Scholar
• Maki PM, Freeman EW, Greendale GA, et al. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause 2010;17:815–22
   PubMed Web of Science ®Google Scholar
• Diniz BS, Butters MA, Albert SM, et al. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013;202:329–35
   PubMed Web of Science ®Google Scholar
• Ownby RL, Crocco E, Acevedo A, et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006;63:530–8
   PubMed Web of Science ®Google Scholar
• Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011;70:960–9
   PubMed Web of Science ®Google Scholar
• Grinberg LT, Rüb U, Ferretti RE, et al. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset?Neuropathol Appl Neurobiol 2009;35:406–16
   PubMed Web of Science ®Google Scholar
• Byers AL, Yaffe K. Depression and risk of developing dementia. Nature Rev Neurol 2011;3:323–31
   Google Scholar
• Green KN, Billings LM, Roozendaal B, et al. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. J Neurosci 2006;30:9047–56
   Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v 1.0, Cancer Incidence and Mortality World Wide: IARC Cancer Base No.11 (internet). Lyon, France: International Agency for Research on Cancer, 2013
   Google Scholar
• Robson M, Offit K. Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 2007; 357:154–62
   PubMed Web of Science ®Google Scholar
• Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test. Hemoccult Cochrane Database Syst Rev2007(1):CD001216
   Google Scholar
• Gompel A, Baber RJ, de Villiers TJ, et al. Oncology in midlife and beyond. Climacteric 2013;16:522–35
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC: World Cancer Research Fund/American Institute for Cancer Research, 2007
   Google Scholar
• Romaguera D, Vergnaud AC, Peeters PH, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr 2012;96:150–63
   PubMed Web of Science ®Google Scholar
• Kushi LH, Doyle C, McCullough M, et al. and the American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012;62:30–67
   PubMed Web of Science ®Google Scholar
• Anderson G. Conjugated equine estrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol 2012;13:476–86
   PubMed Web of Science ®Google Scholar
• Hersh AL, Stefanick ML, Stafford RL. National use of menopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47–53
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Shapiro S. Bias in the evaluation of low-magnitude associations: an empirical perspective. Am J Epidemiol 2000;151:939–945
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: association or causation?Proc R Soc Med 1965;58:295–300
   PubMed Web of Science ®Google Scholar
• Susser M. Causal Thinking in the Health Sciences. New York: Oxford University Press, 1979
   Google Scholar
• Susser M. What is a cause and how do we know one?Am J Epidemiol 1991;133:635–48
   PubMed Web of Science ®Google Scholar
• Anderson GL, Chlebowski RT, Rossouw JE, et al. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006;55:103–15
   PubMed Web of Science ®Google Scholar
• Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause 2011;18:1172–7
   PubMed Web of Science ®Google Scholar
• Islam S, Liu Q, Chines A, Helzner. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000–2005. Menopause 2009;16:77–82
   PubMed Web of Science ®Google Scholar
• Sarrel PM, Njike V, Vinante V, Katz DL. The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women age 50 to 59. Am J Pub Health 2013;103: 1583–8
   PubMed Web of Science ®Google Scholar
• Lobo RA. Where are we 10 years after the Women’s Health Initiative?J Clin Endocrinol Metab 2013;98:1771–80
   PubMed Web of Science ®Google Scholar
• Hodis HN. ELITE – Does the trial outcome confirm or refute the timing hypothesis of hormone therapy? Presented at the14th World Congress on Menopause of the International Menopause Society, May 1–4, 2014, Cancun, Mexico
   Google Scholar
• LaCroix AZ, Chlebowski RT, Manson JE, et al.; WHI Investigators. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305:1305–14
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Cheng J, Thabane L, Buckley NS, Salpeter EE. The cost-effectiveness of hormone therapy in younger and older postmenopausal women. Am J Med 2009;122:45–52
   Google Scholar
• Lekander I, Borgström F, Ström O, et al. Cost-effectiveness of hormone therapy in the United States. J Womens Health 2009; 18:1669–77
   Web of Science ®Google Scholar